Literature DB >> 10516904

Pneumonia in the elderly.

C Feldman1.   

Abstract

Pneumonia, including community-acquired, long-term care facility-associated, and nosocomial infections, is a major cause of morbidity and mortality in the elderly. The aged with pneumonia often present with atypical features, including confusion, lethargy, and general deterioration of condition (so-called "silent infection"). Further investigations, such as a chest radiograph, are more frequently required for diagnosis, but even these results may be normal early in the course of infection, particularly in dehydrated patients. The elderly are more frequently hospitalized for pneumonia and have a greater need for intravenous therapy, longer hospital stay, more prolonged course, greater morbidity, and, ultimately, a poorer outcome. Yet in many studies it is not chronological age per se that impacts negatively on the manifestations of pneumonia in the elderly but rather the presence of comorbid illness. Antibiotic therapy remains the mainstay of therapy for pneumonia, and both community and hospital-based studies confirm the important positive impact of early appropriate empiric antibiotic therapy on outcome. Attention to nutrition and hydration, the use of pneumococcal and influenza vaccination, and a number of diverse procedures in the hospital setting may help limit the occurrence and impact of such infections.

Entities:  

Mesh:

Year:  1999        PMID: 10516904     DOI: 10.1016/s0272-5231(05)70236-7

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  10 in total

1.  Risk of hospitalization due to pneumococcal disease in adults in Spain. The CORIENNE study.

Authors:  Ruth Gil-Prieto; Raquel Pascual-Garcia; Stefan Walter; Alejandro Álvaro-Meca; Ángel Gil-De-Miguel
Journal:  Hum Vaccin Immunother       Date:  2016-02-22       Impact factor: 3.452

Review 2.  Pneumonia in frail older patients: an up to date.

Authors:  Marco Falcone; Francesco Blasi; Francesco Menichetti; Federico Pea; Francesco Violi
Journal:  Intern Emerg Med       Date:  2012-06-12       Impact factor: 3.397

Review 3.  Drug treatment of pneumococcal pneumonia in the elderly.

Authors:  Sridhar Neralla; Keith C Meyer
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

Review 4.  New developments in antibacterial choice for lower respiratory tract infections in elderly patients.

Authors:  Anna Maria Ferrara; Anna Maria Fietta
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

Review 5.  Acute exacerbations of chronic bronchitis in elderly patients: pathogenesis, diagnosis and management.

Authors:  Don Hayes; Keith C Meyer
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

6.  Sphingosine rescues aged mice from pulmonary pseudomonas infection.

Authors:  Teresa C Rice; Amanda M Pugh; Aaron P Seitz; Erich Gulbins; Vanessa Nomellini; Charles C Caldwell
Journal:  J Surg Res       Date:  2017-07-25       Impact factor: 2.192

7.  Mycoplasma pneumoniae outbreak in a long-term care facility--Nebraska, 2014.

Authors:  Deborah L Hastings; Kari J Harrington; Preeta K Kutty; Rebecca J Rayman; Dana Spindola; Maureen H Diaz; Kathleen A Thurman; Jonas M Winchell; Thomas J Safranek
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-03-27       Impact factor: 17.586

Review 8.  The role of immunity in susceptibility to respiratory infection in the aging lung.

Authors:  K C Meyer
Journal:  Respir Physiol       Date:  2001-10

9.  The indirect impact of COVID-19 large-scale containment measures on the incidence of community-acquired pneumonia in older people: a region-wide population-based study in Tuscany, Italy.

Authors:  Vieri Lastrucci; Guglielmo Bonaccorsi; Silvia Forni; Sara D'Arienzo; Letizia Bachini; Sonia Paoli; Chiara Lorini; Fabrizio Gemmi
Journal:  Int J Infect Dis       Date:  2021-07-01       Impact factor: 3.623

10.  The burden of community-acquired pneumonia in the elderly: the Spanish EVAN-65 study.

Authors:  Olga Ochoa-Gondar; Angel Vila-Córcoles; Cinta de Diego; Victoria Arija; Monica Maxenchs; Montserrat Grive; Enrique Martin; Josep L Pinyol
Journal:  BMC Public Health       Date:  2008-06-27       Impact factor: 3.295

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.